Cargando…

Importance of doctor‐initiated management of the balance between work and treatment for lung cancer patients: Results of a nationwide survey by the Japan Lung Cancer Society

BACKGROUNDS: Since the recent development of molecular targeted drugs and immune checkpoint inhibitors has improved lung cancer treatment options and outcomes, supporting patients in balancing work and pharmacotherapy have become even more important in the field of lung cancer treatment. This study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ikeda, Satoshi, Ozawa, Yuichi, Harada, Ken, Hasegawa, Kazuo, Shimizu, Naomi, Seki, Takako, Hasegawa, Yoshinori, Mitsudomi, Tetsuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476847/ https://www.ncbi.nlm.nih.gov/pubmed/32657025 http://dx.doi.org/10.1002/cam4.3307

Ejemplares similares

Growth inhibitory effects of miR-221 and miR-222 in non-small cell lung cancer cells
por: Yamashita, Ryo, et al.
Publicado: (2015)

Salvage surgery after definitive chemoradiotherapy for patients with non-small cell lung cancer
por: Hamada, Akira, et al.
Publicado: (2021)

Development of personalized treatments in lung cancer: focusing on the EGFR mutations and beyond
por: Suda, Kenichi, et al.
Publicado: (2013)

Drug Tolerance to EGFR Tyrosine Kinase Inhibitors in Lung Cancers with EGFR Mutations
por: Suda, Kenichi, et al.
Publicado: (2021)

Detection of AXL expression in circulating tumor cells of lung cancer patients using an automated microcavity array system
por: Ikeda, Mio, et al.
Publicado: (2020)

Not all epidermal growth factor receptor mutations in lung cancer are created equal: Perspectives for individualized treatment strategy
por: Kobayashi, Yoshihisa, et al.
Publicado: (2016)

LDCT lung cancer screening in populations at different risk for lung cancer
por: Teles, Gustavo Borges da Silva, et al.
Publicado: (2020)

Prevalence of pre-existing lung diseases and their association with income level among patients with lung cancer: a nationwide population-based case-control study in South Korea
por: Oh, Chang-Mo, et al.
Publicado: (2023)

Prognostic signature of protocadherin 10 methylation in curatively resected pathological stage I non-small-cell lung cancer
por: Harada, Hiroaki, et al.
Publicado: (2015)

Cell Line Models for Acquired Resistance to First-Line Osimertinib in Lung Cancers—Applications and Limitations
por: Ohara, Shuta, et al.
Publicado: (2021)

Management of Lung Cancer in the Patient with Interstitial Lung Disease
por: Frank, Angela J, et al.
Publicado: (2022)

Prediction of prognosis of patients with lung cancer in combination with the immune score
por: Han, Ke, et al.
Publicado: (2021)

Comprehensive analysis of DTYMK in pan-cancer and verification in lung adenocarcinoma
por: Zhang, Yue, et al.
Publicado: (2022)

Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancer
por: Suda, Kenichi, et al.
Publicado: (2015)

A phase II study of cisplatin plus vinorelbine combined with atezolizumab as adjuvant therapy for completely resected non-small-cell lung cancer with EGFR mutation (West Japan Oncology Group 11719L/ADJUST study)
por: Shibaki, Ryota, et al.
Publicado: (2021)

Perioperative Therapy for Non-Small Cell Lung Cancer with Immune Checkpoint Inhibitors
por: Soh, Junichi, et al.
Publicado: (2021)

Lung Cancer with MET exon 14 Skipping Mutation: Genetic Feature, Current Treatments, and Future Challenges
por: Fujino, Toshio, et al.
Publicado: (2021)

Utility of the Ba/F3 cell system for exploring on‐target mechanisms of resistance to targeted therapies for lung cancer
por: Koga, Takamasa, et al.
Publicado: (2022)

Surgical therapy for pulmonary metastasis of breast cancer
por: Soh, Junichi, et al.
Publicado: (2020)

Impact of somatic mutations on prognosis in resected non‐small‐cell lung cancer: The Japan Molecular Epidemiology for lung cancer study
por: Tamiya, Akihiro, et al.
Publicado: (2020)

The roles of MASPIN expression and subcellular localization in non-small cell lung cancer
por: Wang, Xiao-Fei, et al.
Publicado: (2020)

Prostasin regulates PD-L1 expression in human lung cancer cells
por: Chen, Li-Mei, et al.
Publicado: (2021)

Impact of the shared decision‐making process on lung cancer screening decisions
por: Tan, Naomi Q. P., et al.
Publicado: (2021)

Pretreatment advanced lung cancer inflammation index (ALI) for predicting early progression in nivolumab‐treated patients with advanced non–small cell lung cancer
por: Shiroyama, Takayuki, et al.
Publicado: (2017)

Occupational Diesel Exposure, Duration of Employment, and Lung Cancer: An Application of the Parametric G-Formula
por: Neophytou, Andreas M., et al.
Publicado: (2016)

LINC00205 promotes malignancy in lung cancer by recruiting FUS and stabilizing CSDE1
por: Xie, Peng, et al.
Publicado: (2020)

Treatment- and immune-related adverse events of immune checkpoint inhibitors in advanced lung cancer
por: Shao, Jun, et al.
Publicado: (2020)

Adjuvant therapies in stages I–III epidermal growth factor receptor-mutated lung cancer: current and future perspectives
por: Kris, Mark G., et al.
Publicado: (2023)

Alkenyl group is responsible for the disruption of microtubule network formation in human colon cancer cell line HT-29 cells
por: Hosono, Takashi, et al.
Publicado: (2008)

Changes in survival of patients with non–small cell lung cancer in Japan: An interrupted time series study
por: Taniyama, Yukari, et al.
Publicado: (2022)

Exploring the mechanism of aidi injection for lung cancer by network pharmacology approach and molecular docking validation
por: Zhuang, Zhenjie, et al.
Publicado: (2021)

Lung cancer specialists' opinions on treatment for stage I non-small cell lung cancer: A multidisciplinary survey
por: Lammers, Austin, et al.
Publicado: (2018)

Occupational class and male cancer incidence: Nationwide, multicenter, hospital‐based case–control study in Japan
por: Zaitsu, Masayoshi, et al.
Publicado: (2019)

How lung cancer cells change identity
por: von Itzstein, Mitchell S, et al.
Publicado: (2021)

Impact of Preexisting Interstitial Lung Disease on Acute, Extensive Radiation Pneumonitis: Retrospective Analysis of Patients with Lung Cancer
por: Ozawa, Yuichi, et al.
Publicado: (2015)

Role of lung and gut microbiota on lung cancer pathogenesis
por: Zhao, Yue, et al.
Publicado: (2021)

Risk factors for pulmonary infection after diagnostic bronchoscopy in patients with lung cancer
por: Shimizu, Takahiro, et al.
Publicado: (2020)

Risk of Lung Cancer Mortality in Nuclear Workers from Internal Exposure to Alpha Particle-emitting Radionuclides
por: Grellier, James, et al.
Publicado: (2017)

Knockdown of CRAD suppresses the growth and promotes the apoptosis of human lung cancer cells via Claudin 4
por: Cui, Anfang, et al.
Publicado: (2020)

Meta-analysis of diagnostic and prognostic value of miR-126 in non-small cell lung cancer
por: Sun, Lin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jotd3sdrjfgbs8q204cc7ctbgp